Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Adesso BioProducts AB
AB
Active
Org 5567285779
Verkmästarvägen 10, 444 32
Stenungsund
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2007 · 19 years old
5 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Adesso BioProducts AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
3.4B
2.5B
1.7B
0.8B
-0.0B
2020: 1.9B
1.9B
2020
2021: 2.5B (+31% vs 2020)
2.5B
+31%
2021
2022: 2.7B (+9% vs 2021)
2.7B
+9%
2022
2023: 2.7B (-2% vs 2022)
2.7B
-2%
2023
2024: 1.7B (-35% vs 2023)
1.7B
-35%
2024
EBITDA
SEK millions
262M
196M
131M
65M
0M
2020: 104M
104M
2020
2021: 180M (+73% vs 2020)
180M
+73%
2021
2022: 171M (-5% vs 2021)
171M
-5%
2022
2023: 210M (+23% vs 2022)
210M
+23%
2023
2024: 179M (-15% vs 2023)
179M
-15%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
1 727 619
2 662 233
2 727 943
2 501 893
1 910 230
Staff expenses
—
—
—
—
—
EBITDA
179 123
210 169
170 697
180 412
104 192
Depreciation & amort.
−237
−237
−229
−154
−36
EBIT
178 886
209 932
170 468
180 258
104 156
Net financials
3 388
−13 337
−9 796
−10 581
−10 972
Profit before tax
182 806
101 057
160 671
169 676
93 184
Tax
−37 602
−20 753
−33 136
−34 965
−19 948
Net profit
145 204
80 304
127 535
134 711
73 236
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
849 542
804 236
873 721
801 910
537 450
Equity
597 874
478 670
418 365
300 830
176 118
Long-term debt
80 000
80 000
134 600
134 600
134 600
Short-term debt
171 668
245 566
320 756
366 480
226 732
Total debt
251 668
325 566
455 356
501 080
361 332
Financial ratios
5-year trend
EBITDA margin
10,4 %
This company
15,8 %
Market median
This company
Market median
34% below market
2020
2024
Equity ratio
70,4 %
This company
38,2 %
Market median
This company
Market median
84% above market
2020
2024
Return on equity
24,3 %
This company
18,4 %
Market median
This company
Market median
32% above market
2020
2024
Net profit margin
8,4 %
This company
8,1 %
Market median
This company
Market median
4% above market
2020
2024
Asset turnover
2,03×
This company
1,12×
Market median
This company
Market median
81% above market
2020
2024
Debt / equity
0,42×
This company
0,62×
Market median
This company
Market median
32% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Adesso BioProducts AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
